Victory Capital Management Inc. raised its holdings in Cano Health, Inc. (NYSE:CANO – Free Report) by 39.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,487 shares of the company’s stock after buying an additional 7,757 shares during the period. Victory Capital Management Inc.’s holdings in Cano Health were worth $38,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of CANO. Raymond James & Associates raised its stake in Cano Health by 12.1% in the first quarter. Raymond James & Associates now owns 125,611 shares of the company’s stock valued at $798,000 after buying an additional 13,593 shares in the last quarter. Raymond James Financial Services Advisors Inc. increased its position in shares of Cano Health by 18.6% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 169,145 shares of the company’s stock worth $1,074,000 after purchasing an additional 26,550 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Cano Health by 19.2% during the first quarter. Bank of New York Mellon Corp now owns 78,241 shares of the company’s stock worth $497,000 after purchasing an additional 12,578 shares in the last quarter. HighTower Advisors LLC acquired a new stake in shares of Cano Health during the first quarter worth about $129,000. Finally, Allianz Asset Management GmbH acquired a new stake in shares of Cano Health during the first quarter worth about $2,268,000. 35.99% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on CANO shares. Citigroup cut Cano Health from a “buy” rating to a “neutral” rating and cut their target price for the stock from $4.00 to $0.80 in a research report on Friday, August 11th. Jefferies Financial Group cut Cano Health from a “buy” rating to a “hold” rating in a research report on Friday, August 11th. One investment analyst has rated the stock with a sell rating and seven have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $2.08.
Cano Health Stock Performance
NYSE CANO opened at $12.07 on Tuesday. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 3.95. Cano Health, Inc. has a 52-week low of $9.62 and a 52-week high of $378.00. The business’s 50-day moving average price is $0.68 and its 200 day moving average price is $1.02. The firm has a market cap of $65.02 million, a P/E ratio of -8.21 and a beta of 0.43.
Cano Health (NYSE:CANO – Get Free Report) last released its quarterly earnings results on Thursday, August 10th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.19). Cano Health had a negative return on equity of 13.40% and a negative net margin of 12.47%. The company had revenue of $766.75 million for the quarter, compared to analysts’ expectations of $837.65 million. On average, equities research analysts expect that Cano Health, Inc. will post -0.82 earnings per share for the current year.
Cano Health Company Profile
Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.
- Five stocks we like better than Cano Health
- What is the Dogs of the Dow Strategy? Overview and Examples
- These 5 small-cap impact stocks are making social change
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Alphabet slays its earnings but falls on its sword with cloud
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- There’s nothing artificial about NVIDIA’s relationship with AI
Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.